What Broadreach Global does

Broadreach Global is a Miami-based boutique advisory firm operating at the intersection of neuroscience innovation, investment, and industry. Its core activity is bespoke strategic advisory to private neuroscience biotech companies, neuroscience-focused investment funds, and the neuroscience business units of large pharma, covering strategy development, advisory board construction, investor identification, pharma partnership engagement, and BD&L strategy. The firm's commercial model rests on a second offering — an event ecosystem built around two flagship convenings: the annual Bio-Neuroscience summit in Amsterdam (now in its third edition for 2027) and the Gene4Neuro forum in Pamplona, which together aggregate a 200+ person network of biotech CEOs, pharma BD&L heads, VCs, and KOLs. Sponsorship and registration revenue from these events, alongside multi-year advisory retainers, comprise the two revenue streams.

The firm has no technology product or platform; its underlying capability is relationship capital curated over more than two decades, anchored by Founder & CEO Christian J. Suojanen's 25-year track record in bio-health strategy, business development, and investment, and his advisory roles with the European Brain Council, Applied Neuroscience Association, and European Brain Foundation Board. Distribution is deliberately high-touch and event-driven — clients and sponsors are acquired through direct outreach, ecosystem referrals, summit participation, and a content-marketing surface (Gene4Neuro blog), with the firm engaging only a small number of priority partners each year to maintain engagement depth and pricing power.

Name

Broadreach Global

Legal name

Broadreach Global LLC

Website

https://broadreach-global.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

Broadreach Global is a Miami-based boutique advisory firm that provides bespoke strategy, advisory board, investor identification, and pharma partnership services to neuroscience biotechs, specialist VCs, and pharma BD&L teams, anchored by two annual events — Bio-Neuroscience and Gene4Neuro — that convene a 200+ person global network.

Ownership category

akta.pro rank

Product category

Biotech / Life Sciences Advisory Services

NAICS

Management Consulting Services (54161), Portfolio Management and Investment Advice (523940)

SIC

Services-Management Consulting Services (8742), Investment Advice (6282)

akta.pro primary industry

Strategy & Corporate Development Consulting (BPAHACAA)

akta.pro secondary industries

Corporate Development & Strategic Partnerships Advisory (JVs, Alliances, Carve-outs) (BPAHAOAG), M&A Advisory (Buy-side/Sell-side) (BPAHADAC), Strategic Partnerships, Alliances & JVs Advisory (BPAHADAI)

Keywords

• Biotech advisory services
• Neuroscience consulting
• CNS drug development
• Pharma partnership strategy
• Life sciences investment advisory

Headquarters

HQ city

Miami

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations

Revenue model

1. Advisory & Strategic Consulting: Broadreach Global provides bespoke advisory engagements to biotech companies, investors, and pharma organizations. Services include strategic planning, advisory board construction, investor identification, pharma partnership strategy, and business development and licensing strategy. Engagements are highly customized and relationship-based, drawing on the firm's deep network access. Fees are likely project-based or retainer arrangements given the bespoke nature of the work.
2. Event Sponsorship & Registration: The company generates revenue through sponsorship fees and participant registration for its Bio-Neuroscience and Gene4Neuro summits. Sponsors include pharmaceutical companies (e.g., Sanofi, Merz Therapeutics, EQT Life Sciences), biotechs, and service providers. Registration fees are charged to attendees. The events are strictly limited in capacity, creating exclusivity and premium pricing.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

Core offering

Broadreach Global is a boutique advisory firm providing bespoke strategic advisory engagements to neuroscience biotech companies, investors, and pharma organizations — covering strategy development, advisory board construction, investor identification, pharma partnership engagement, and business development and licensing strategy. The firm complements its advisory practice with two flagship event ecosystems: the annual Bio-Neuroscience partnering and investment summit in Amsterdam and the Gene4Neuro gene therapy forum series in Pamplona.

Product overview

Broadreach Global is a boutique advisory firm operating at the intersection of neuroscience innovation, investment, and industry. The company offers two integrated offerings: (1) Advisory Services providing relationship-based strategic advisory to biotech companies, investors, and pharma organizations in neuroscience, and (2) Event Ecosystems including the Bio-Neuroscience annual summit and Gene4Neuro initiative. These offerings work together — the advisory practice draws on the company's network built through its events, while the events serve as convening platforms that facilitate connections among the same stakeholders the advisory team serves.

Differentiator

Problem solved

Functional benefit

Brands

• Bio-Neuroscience: The premier gathering for global leaders in CNS neuroscience drug discovery and development, organized by Broadreach Global as an annual summit event.
• Gene4Neuro

Products and services

• Advisory Services Boutique advisory engagement for biotech companies, investors, and pharma leaders in neuroscience. Services include strategy development, advisory board composition, investor identification, pharma partnership engagement, and business development and licensing strategy — delivered through deep sector knowledge and relationship-based access.
• Bio-Neuroscience Summit Exclusive annual partnering and investment summit for global leaders in CNS neuroscience drug discovery and development. The event convenes biotech CEOs, investors, and pharma decision-makers for three days of high-level plenary sessions, interactive roundtables, and networking designed for genuine engagement and deal-making. Held annually in Amsterdam.
• Gene4Neuro Forum Series Specialized forum series focused on gene therapy for neurological disease. Brings together scientists, CEOs, investors, clinicians, and patient families for expert conversations on delivery, modalities, clinical development, pricing, safety, and access to genetic medicines for brain disease. Held in Pamplona.

Quantifiable outcome

• 200+ biotech CEOs, investors & pharma decision-makers convene at the annual Bio-Neuroscience summit
• +1 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Four partnerships are on record, tiered core and minor.

• Amsterdam NeurosciencecoreStrategic or Co-development PartnerAmsterdam Neuroscience serves as Co-organizer & Host Partner for the Bio-Neuroscience summit series. This is a foundational partnership — the event is held in Amsterdam at Hotel Jakarta, and Amsterdam Neuroscience provides institutional credibility, scientific endorsement, and distribution reach within the European neuroscience research ecosystem. The 2027 edition of Bio-Neuroscience is co-organized with Amsterdam Neuroscience.
• European Brain Council (EBC)coreStrategic or Co-development PartnerThe European Brain Council is a Partner of Bio-Neuroscience and Broadreach Global is a proud supporter of the EBC's call to prioritize brain health at EU policy agendas. Christian Suojanen is an advisor to the European Brain Council, creating a direct institutional link. This partnership positions the events within the broader European brain health policy context.
• SanoficoreStrategic or Co-development PartnerSanofi is represented on the Bio-Neuroscience 2027 Advisory Board by Pablo Sardi, Global Head, Rare & Neurologic Diseases Therapeutic Area. Pablo Sardi delivered the opening keynote at Gene4Neuro 2025. Sanofi represents a major pharma perspective in the event's programming and strategic direction.
• EffectiaminorStrategic or Co-development PartnerEffectia is listed as a Strategic Partner of Bio-Neuroscience. The partnership contributes to the event's strategic reach, particularly within the European innovation ecosystem.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• L.E.K. Consulting: Global strategy consultancy with a large life sciences practice serving pharma, biotech, and investors — a broad incumbent offering overlapping capabilities in pharma/biotech strategy and BD&L, but not specialized in the CNS/neuroscience niche.
• ZS Associates: Large global management consulting firm with deep pharma and biotech practices — a broad incumbent that competes for strategic advisory and BD&L engagements in life sciences, though with a much broader and less CNS-specialized offering.

Direct peers

• Locust Walk: Life sciences-focused transaction and strategic advisory firm representing biotech companies in financings, partnerships, and M&A — directly comparable to Broadreach's BD&L and investor-identification work in CNS.
• Back Bay Life Science Advisors: Boutique strategic advisory and transaction firm focused on life sciences companies, investors, and pharma — directly comparable to Broadreach's advisory and partnership-strategy work with biotech and pharma clients.
• Trinity Partners: Life sciences-focused strategic consulting and advisory firm serving biotech and pharma on commercial strategy, pipeline, and transactions — directly comparable as a boutique advisor in the same client segment as Broadreach.
• Defined Health (Cello Health): Therapeutic strategy consultancy serving emerging biotech and pharma with pipeline, partnership, and commercialization advisory — directly comparable in service line and biotech-client focus to Broadreach Global.
• Alacrita Consulting: Boutique pharma and biotech consulting firm offering commercial, scientific, and strategic advisory — directly comparable as a small, specialist advisory competing for similar biotech and pharma engagements.
• Torreya Partners: Global life sciences investment banking and advisory firm specializing in M&A, licensing, and strategic transactions in pharma and biotech — directly comparable to Broadreach's advisory work on partnerships, licensing, and strategic transactions.
• ClearView Healthcare Partners: Boutique life sciences strategy consulting firm serving biotech, pharma, and investors with commercial, pipeline, and BD&L advisory — directly comparable in service offering, target client, and relationship-driven model to Broadreach Global.
• EBD Group (Informa): Operates BIO-Europe and other global life sciences partnering events and runs the partneringONE platform — directly comparable as a life sciences summit and partnering-conference operator with a similar biotech-investor-pharma audience.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/broadreach-global
• Facebookfacebook.com/BroadreachGlobal

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Broadreach Global